Cycloviolacin O2-Lys(Ac2)

General Information


DRACP ID  DRACP04791

Peptide Name   Cycloviolacin O2-Lys(Ac2)

Sequence  GIPCGESCVWIPCISSAIGCSCXSXVCYRN

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C121H187N33O36S6

Absent amino acids  DFHKLMQT

Common amino acids  C

Mass  360983

Pl  5.94

Basic residues  1

Acidic residues  1

Hydrophobic residues  8

Net charge  0

Boman Index  -311

Hydrophobicity  70.33

Aliphatic Index  74.67

Half Life 
  /

Extinction Coefficient cystines  7365

Absorbance 280nm  253.97

Polar residues  16

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18618891

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 16389447

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12170

DRACP is developed by Dr.Zheng's team.